{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T21:04:39Z","timestamp":1775423079549,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/leu.2009.19","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T15:36:27Z","timestamp":1235057787000},"page":"1320-1328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy"],"prefix":"10.1038","volume":"23","author":[{"given":"M","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"BFleu200919_CR1","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1182\/blood-2006-11-057208","volume":"109","author":"M Pinyol","year":"2007","unstructured":"Pinyol M, Bea S, Pla L, Ribrag V, Bosq J, Rosenwald A et al. Inactivation of RB1 in mantle-cell lymphoma detected by nonsense-mediated mRNA decay pathway inhibition and microarray analysis. Blood 2007; 109: 5422\u20135429.","journal-title":"Blood"},{"issue":"Suppl 4","key":"BFleu200919_CR2","doi-asserted-by":"publisher","first-page":"iv12","DOI":"10.1093\/annonc\/mdj992","volume":"17","author":"AD Zelenetz","year":"2006","unstructured":"Zelenetz AD . Mantle cell lymphoma: an update on management. Ann Oncol 2006; 17 (Suppl 4): iv12\u2013iv14.","journal-title":"Ann Oncol"},{"key":"BFleu200919_CR3","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1517\/14728222.11.7.929","volume":"11","author":"P Martin","year":"2007","unstructured":"Martin P, Leonard JP . Novel therapeutic targets in mantle cell lymphoma. Expert Opin Ther Targets 2007; 11: 929\u2013940.","journal-title":"Expert Opin Ther Targets"},{"key":"BFleu200919_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2141.2007.06908.x","volume":"140","author":"AM Evens","year":"2008","unstructured":"Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D et al. A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma. Br J Haematol 2008; 140: 385\u2013393.","journal-title":"Br J Haematol"},{"key":"BFleu200919_CR5","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.biocel.2007.04.026","volume":"39","author":"F Bertoni","year":"2007","unstructured":"Bertoni F, Ponzoni M . The cellular origin of mantle cell lymphoma. Int J Biochem Cell Biol 2007; 39: 1747\u20131753.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFleu200919_CR6","first-page":"115","volume":"36","author":"E Campo","year":"1999","unstructured":"Campo E, Raffeld M, Jaffe ES . Mantle-cell lymphoma. Semin Hematol 1999; 36: 115\u2013127.","journal-title":"Semin Hematol"},{"key":"BFleu200919_CR7","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1172\/JCI32446","volume":"117","author":"CH June","year":"2007","unstructured":"June CH . Adoptive T cell therapy for cancer in the clinic. J Clin Invest 2007; 117: 1466\u20131476.","journal-title":"J Clin Invest"},{"key":"BFleu200919_CR8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1182\/blood.V95.4.1342.004k19_1342_1349","volume":"95","author":"F Osterroth","year":"2000","unstructured":"Osterroth F, Garbe A, Fisch P, Veelken H . Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells. Blood 2000; 95: 1342\u20131349.","journal-title":"Blood"},{"key":"BFleu200919_CR9","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1182\/blood.V89.10.3806","volume":"89","author":"JL Schultze","year":"1997","unstructured":"Schultze JL, Seamon MJ, Michalak S, Gribben JG, Nadler LM . Autologous tumor infiltrating T cells cytotoxic for follicular lymphoma cells can be expanded in vitro. Blood 1997; 89: 3806\u20133816.","journal-title":"Blood"},{"key":"BFleu200919_CR10","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1182\/blood.V97.6.1750","volume":"97","author":"YJ Wen","year":"2001","unstructured":"Wen YJ, Barlogie B, Yi Q . Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells. Blood 2001; 97: 1750\u20131755.","journal-title":"Blood"},{"key":"BFleu200919_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJM199210223271705","volume":"327","author":"LW Kwak","year":"1992","unstructured":"Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R . Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 1992; 327: 1209\u20131215.","journal-title":"N Engl J Med"},{"key":"BFleu200919_CR12","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1182\/blood-2007-03-080507","volume":"111","author":"SN Franki","year":"2008","unstructured":"Franki SN, Steward KK, Betting DJ, Kafi K, Yamada RE, Timmerman JM . Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B-cell lymphoma in vivo. Blood 2008; 111: 1504\u20131511.","journal-title":"Blood"},{"key":"BFleu200919_CR13","doi-asserted-by":"publisher","first-page":"6364","DOI":"10.1200\/JCO.2005.05.019","volume":"23","author":"V Fernandez","year":"2005","unstructured":"Fernandez V, Hartmann E, Ott G, Campo E, Rosenwald A . Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways. J Clin Oncol 2005; 23: 6364\u20136369.","journal-title":"J Clin Oncol"},{"key":"BFleu200919_CR14","doi-asserted-by":"crossref","first-page":"424","DOI":"10.5858\/2003-127-0424-COMCLC","volume":"127","author":"HM Amin","year":"2003","unstructured":"Amin HM, McDonnell TJ, Medeiros LJ, Rassidakis GZ, Leventaki V, O\u2019Connor SL et al. Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med 2003; 127: 424\u2013431.","journal-title":"Arch Pathol Lab Med"},{"key":"BFleu200919_CR15","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E . Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer 2007; 7: 750\u2013762.","journal-title":"Nat Rev Cancer"},{"key":"BFleu200919_CR16","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1038\/leu.2008.213","volume":"22","author":"M Klier","year":"2008","unstructured":"Klier M, Anastasov N, Hermann A, Meindl T, Angermeier D, Raffeld M et al. Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2. Leukemia 2008; 22: 2097\u20132105.","journal-title":"Leukemia"},{"key":"BFleu200919_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0022-1759(96)00078-6","volume":"196","author":"N Romani","year":"1996","unstructured":"Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 1996; 196: 137\u2013151.","journal-title":"J Immunol Methods"},{"key":"BFleu200919_CR18","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1084\/jem.179.4.1109","volume":"179","author":"F Sallusto","year":"1994","unstructured":"Sallusto F, Lanzavecchia A . Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte\/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 1109\u20131118.","journal-title":"J Exp Med"},{"key":"BFleu200919_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1046\/j.1365-3083.1998.00284.x","volume":"47","author":"D Anton","year":"1998","unstructured":"Anton D, Dabadghao S, Palucka K, Holm G, Yi Q . Generation of dendritic cells from peripheral blood adherent cells in medium with human serum. Scand J Immunol 1998; 47: 116\u2013121.","journal-title":"Scand J Immunol"},{"key":"BFleu200919_CR20","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1002\/eji.1830230603","volume":"23","author":"HW Nijman","year":"1993","unstructured":"Nijman HW, Houbiers JG, Vierboom MP, van der Burg SH, Drijfhout JW, D\u2019Amaro J et al. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes. Eur J Immunol 1993; 23: 1215\u20131219.","journal-title":"Eur J Immunol"},{"key":"BFleu200919_CR21","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1182\/blood-2007-03-082529","volume":"110","author":"J Qian","year":"2007","unstructured":"Qian J, Xie J, Hong S, Yang J, Zhang L, Han X et al. Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma. Blood 2007; 110: 1587\u20131594.","journal-title":"Blood"},{"key":"BFleu200919_CR22","doi-asserted-by":"publisher","first-page":"8808","DOI":"10.1158\/1078-0432.CCR-05-1553","volume":"11","author":"J Qian","year":"2005","unstructured":"Qian J, Wang S, Yang J, Xie J, Lin P, Freeman ME et al. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96. Clin Cancer Res 2005; 11: 8808\u20138815.","journal-title":"Clin Cancer Res"},{"key":"BFleu200919_CR23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1046\/j.1440-1711.1999.00870.x","volume":"77","author":"D Fulcher","year":"1999","unstructured":"Fulcher D, Wong S . Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol Cell Biol 1999; 77: 559\u2013564.","journal-title":"Immunol Cell Biol"},{"key":"BFleu200919_CR24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1365-3083.1993.tb03236.x","volume":"38","author":"Q Yi","year":"1993","unstructured":"Yi Q, Bergenbrant S, Osterborg A, Osby E, Ostman R, Bjorkholm M et al. T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scand J Immunol 1993; 38: 529\u2013534.","journal-title":"Scand J Immunol"},{"key":"BFleu200919_CR25","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood.V86.8.3043.3043","volume":"86","author":"Q Yi","year":"1995","unstructured":"Yi Q, Osterborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK . Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood 1995; 86: 3043\u20133049.","journal-title":"Blood"},{"key":"BFleu200919_CR26","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1002\/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R","volume":"30","author":"S Tourdot","year":"2000","unstructured":"Tourdot S, Scardino A, Saloustrou E, Gross DA, Pascolo S, Cordopatis P et al. A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes. Eur J Immunol 2000; 30: 3411\u20133421.","journal-title":"Eur J Immunol"},{"key":"BFleu200919_CR27","doi-asserted-by":"publisher","first-page":"948","DOI":"10.4049\/jimmunol.165.2.948","volume":"165","author":"JL Chen","year":"2000","unstructured":"Chen JL, Dunbar PR, Gileadi U, Jager E, Gnjatic S, Nagata Y et al. Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol 2000; 165: 948\u2013955.","journal-title":"J Immunol"},{"key":"BFleu200919_CR28","doi-asserted-by":"publisher","first-page":"11276","DOI":"10.1073\/pnas.88.24.11276","volume":"88","author":"TJ Tsomides","year":"1991","unstructured":"Tsomides TJ, Walker BD, Eisen HN . An optimal viral peptide recognized by CD8+ T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc Natl Acad Sci USA 1991; 88: 11276\u201311280.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu200919_CR29","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1182\/blood.V97.1.114","volume":"97","author":"J Dyall","year":"2001","unstructured":"Dyall J, Latouche JB, Schnell S, Sadelain M . Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes. Blood 2001; 97: 114\u2013121.","journal-title":"Blood"},{"key":"BFleu200919_CR30","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.4049\/jimmunol.146.7.2088","volume":"146","author":"R de Jong","year":"1991","unstructured":"de Jong R, Brouwer M, Miedema F, van Lier RA . Human CD8+ T lymphocytes can be divided into CD45RA+ and CD45RO+ cells with different requirements for activation and differentiation. J Immunol 1991; 146: 2088\u20132094.","journal-title":"J Immunol"},{"key":"BFleu200919_CR31","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1084\/jem.20061692","volume":"203","author":"BS Cobb","year":"2006","unstructured":"Cobb BS, Hertweck A, Smith J, O\u2019Connor E, Graf D, Cook T et al. A role for Dicer in immune regulation. J Exp Med 2006; 203: 2519\u20132527.","journal-title":"J Exp Med"},{"key":"BFleu200919_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/S0952-7915(03)00037-2","volume":"15","author":"DL Woodland","year":"2003","unstructured":"Woodland DL, Dutton RW . Heterogeneity of CD4(+) and CD8(+) T cells. Curr Opin Immunol 2003; 15: 336\u2013342.","journal-title":"Curr Opin Immunol"},{"key":"BFleu200919_CR33","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/eji.200324567","volume":"34","author":"B Pulendran","year":"2004","unstructured":"Pulendran B, Dillon S, Joseph C, Curiel T, Banchereau J, Mohamadzadeh M . Dendritic cells generated in the presence of GM-CSF plus IL-15 prime potent CD8+ Tc1 responses in vivo. Eur J Immunol 2004; 34: 66\u201373.","journal-title":"Eur J Immunol"},{"key":"BFleu200919_CR34","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/eji.200425847","volume":"35","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Renkvist N, Sun Z, Schuler-Thurner B, Glaichenhaus N, Schuler G et al. A polyclonal anti-vaccine CD4 T cell response detected with HLA-DP4 multimers in a melanoma patient vaccinated with MAGE-3.DP4-peptide-pulsed dendritic cells. Eur J Immunol 2005; 35: 1066\u20131075.","journal-title":"Eur J Immunol"},{"key":"BFleu200919_CR35","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1172\/JCI21926","volume":"113","author":"JA Berzofsky","year":"2004","unstructured":"Berzofsky JA, Terabe M, Oh S, Belyakov IM, Ahlers JD, Janik JE et al. Progress on new vaccine strategies for the immunotherapy and prevention of cancer. J Clin Invest 2004; 113: 1515\u20131525.","journal-title":"J Clin Invest"},{"key":"BFleu200919_CR36","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1074-7613(00)80066-7","volume":"10","author":"RH Vonderheide","year":"1999","unstructured":"Vonderheide RH, Hahn WC, Schultze JL, Nadler LM . The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10: 673\u2013679.","journal-title":"Immunity"},{"key":"BFleu200919_CR37","first-page":"3343","volume":"7","author":"RH Vonderheide","year":"2001","unstructured":"Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM . Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res 2001; 7: 3343\u20133348.","journal-title":"Clin Cancer Res"},{"key":"BFleu200919_CR38","first-page":"4845","volume":"60","author":"M Schmitz","year":"2000","unstructured":"Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D et al. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 2000; 60: 4845\u20134849.","journal-title":"Cancer Res"},{"key":"BFleu200919_CR39","first-page":"869","volume":"61","author":"MH Andersen","year":"2001","unstructured":"Andersen MH, Pedersen LO, Becker JC, Straten PT . Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients. Cancer Res 2001; 61: 869\u2013872.","journal-title":"Cancer Res"},{"key":"BFleu200919_CR40","first-page":"6523","volume":"9","author":"V Pisarev","year":"2003","unstructured":"Pisarev V, Yu B, Salup R, Sherman S, Altieri DC, Gabrilovich DI . Full-length dominant-negative survivin for cancer immunotherapy. Clin Cancer Res 2003; 9: 6523\u20136533.","journal-title":"Clin Cancer Res"},{"key":"BFleu200919_CR41","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1172\/JCI200419418","volume":"113","author":"DA Gross","year":"2004","unstructured":"Gross DA, Graff-Dubois S, Opolon P, Cornet S, Alves P, Bennaceur-Griscelli A et al. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J Clin Invest 2004b; 113: 425\u2013433.","journal-title":"J Clin Invest"},{"key":"BFleu200919_CR42","first-page":"169","volume":"116","author":"H Kuriyama","year":"2004","unstructured":"Kuriyama H, Shimizu K, Lee W, Kjaergaard J, Parkhurst MR, Cohen PA et al. Therapeutic vaccine generated by electrofusion of dendritic cells and tumour cells. Dev Biol (Basel) 2004; 116: 169\u2013178; discussion 179\u2013186.","journal-title":"Dev Biol (Basel)"},{"key":"BFleu200919_CR43","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1016\/j.vaccine.2004.08.007","volume":"23","author":"K Otto","year":"2005","unstructured":"Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LO, Rath JC et al. Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin. Vaccine 2005; 23: 884\u2013889.","journal-title":"Vaccine"},{"key":"BFleu200919_CR44","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1182\/blood-2006-04-016634","volume":"108","author":"M Marzec","year":"2006","unstructured":"Marzec M, Kasprzycka M, Lai R, Gladden AB, Wlodarski P, Tomczak E et al. Mantle cell lymphoma cells express predominantly cyclin D1a isoform and are highly sensitive to selective inhibition of CDK4 kinase activity. Blood 2006; 108: 1744\u20131750.","journal-title":"Blood"},{"key":"BFleu200919_CR45","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1200\/JCO.2005.55.017","volume":"23","author":"TE Witzig","year":"2005","unstructured":"Witzig TE . Current treatment approaches for mantle-cell lymphoma. J Clin Oncol 2005; 23: 6409\u20136414.","journal-title":"J Clin Oncol"},{"key":"BFleu200919_CR46","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1101\/gad.7.8.1559","volume":"7","author":"DE Quelle","year":"1993","unstructured":"Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7: 1559\u20131571.","journal-title":"Genes Dev"},{"key":"BFleu200919_CR47","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.canlet.2007.07.015","volume":"256","author":"XL Lu","year":"2007","unstructured":"Lu XL, Jiang XB, Liu RE, Zhang FC, Zhao HY . Generation of allo-restricted cytotoxic T lymphocytes against malignant glioma by artificial antigen-presenting cells. Cancer Lett 2007; 256: 128\u2013135.","journal-title":"Cancer Lett"},{"key":"BFleu200919_CR48","first-page":"1927","volume":"92","author":"B Coiffier","year":"1998","unstructured":"Coiffier B, Haioun C, Ketterer N, Engert A, Tilly H, Ma D et al. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood 1998; 92: 1927\u20131932.","journal-title":"Blood"},{"key":"BFleu200919_CR49","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"16","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin P, Grillo-Lopez AJ, Link BK, Levy R, Czuczman MS, Williams ME et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998; 16: 2825\u20132833.","journal-title":"J Clin Oncol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu200919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200919","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu200919.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T03:00:02Z","timestamp":1684897202000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu200919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFleu200919"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.19","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"5 September 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}